🔎 Trials Near Me

Hjem › Akut myelogen leukemi › New Jersey › Edison

Kliniske studier for Akut myelogen leukemi i Edison, NJ

20 studier for Akut myelogen leukemi søker deltakere på steder i og rundt Edison (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

RekruttererFase 1
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06484062

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

RekruttererFase 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
Alder 18 til 59 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT05554393

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RekruttererFase 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

RekruttererFase 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06317649

A Study of CRD3874-SI in People With Leukemia

RekruttererFase 1
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07661095

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

RekruttererFase 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

RekruttererFase 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
Alder 18 til 59 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RekruttererFase 3
  • Saint Peter's University Hospital, New Brunswick · 3 mi unna
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi unna
6 Months – 21 Years · Alle kjønn · Oppdatert 17. sep. 2026 · NCT04293562

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

RekruttererFase 1/2
  • Saint Peter's University Hospital, New Brunswick · 3 mi unna
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi unna
Opp til 22 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04726241

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

RekruttererFase 3
  • Rutgers Biomedical and Health Sciences, New Brunswick · 3 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT07007312

A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

RekruttererFase 2
  • Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi unna
Alder 60 og eldre · Alle kjønn · Oppdatert 17. jul. 2026 · NCT07392242

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RekruttererObservasjonsstudie
  • Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick · 3 mi unna
Alle aldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT01351545

A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

RekruttererFase 1
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 22. jun. 2026 · NCT05756777

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

RekruttererFase 1
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi unna
Alder 1 og eldre · Alle kjønn · Oppdatert 22. jun. 2026 · NCT06017258

A Study of Revumenib and Mezigdomide in People With Leukemia

RekruttererFase 1/2
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi unna
Alder 12 og eldre · Alle kjønn · Oppdatert 22. jun. 2026 · NCT07356154

A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

RekruttererFase 1
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi unna
Alder 18 til 70 · Alle kjønn · Oppdatert 17. jun. 2026 · NCT07011004

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

RekruttererFase 1/2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
Alder 12 og eldre · Alle kjønn · Oppdatert 24. mar. 2026 · NCT04988555

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

RekruttererFase 1
  • Rutgers Cancer Institute, New Brunswick · 3 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 13. mar. 2026 · NCT05735184

A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

RekruttererFase 1
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 10. mar. 2026 · NCT05748197

A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

RekruttererFase 2
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 24. feb. 2026 · NCT06773208

Akut myelogen leukemi-studier i andre byer

Andre studier i Edison

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.